Repurposing of respiratory drug theophylline againstCandida albicans: mechanistic insights unveil alterations in membrane properties and metabolic fitness
Open Access
- 22 April 2020
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Applied Microbiology
- Vol. 129 (4), 860-875
- https://doi.org/10.1111/jam.14669
Abstract
Aims Drug repurposing is an attractive chemotherapeutic strategy that serves to make up for the inadequacy of current antifungal drugs. The present study aims to repurpose theophylline (THP) against Candida albicans. THP is a methylxanthine derived from cocoa beans and tea extracts, generally used as the first‐line drug for asthma and other respiratory disorders. Methods and Results We investigated the antifungal activity of THP against C. albicans and non‐albicans species. Mechanistic insights revealed that THP induces membrane damage. Enhanced ionic disturbances, depleted ergosterol levels with the concomitant rise in membrane fluidity due to elevated flippase activity confirmed the membrane damaging effect. THP impeded the metabolic adaptability of C. albicans by inhibiting malate synthase and isocitrate lyase enzymes of the glyoxylate cycle. In vivo efficacy of THP was depicted by increased survival of C. albicans infected Caenorhabditis elegans model. Conclusions This study elucidates the antifungal potential of THP with mechanistic insights. Significance and Impact of Study This study unveils the antifungal potential of THP, a known respiratory drug that can be further utilized for a wider range of applications such as combating fungal infections. The effect of THP with the known antifungal drugs can be exploited in the combinatorial drug approach for treating candidiasis.Keywords
This publication has 46 references indexed in Scilit:
- The Mechanism of Antifungal Action of Essential Oil from Dill (Anethum graveolens L.) on Aspergillus flavusPLOS ONE, 2012
- Genome-wide analysis of intracellular pH reveals quantitative control of cell division rate by pHc in Saccharomyces cerevisiaeGenome Biology, 2012
- The activity of the glyoxylate cycle in peroxisomes of Candida albicans depends on a functional β-oxidation pathway: evidence for reduced metabolite transport across the peroxisomal membraneMicrobiology, 2008
- Antifungal Chemical Compounds Identified Using a C. elegans Pathogenicity AssayPLoS Pathogens, 2007
- Epidemiology of Invasive Candidiasis: a Persistent Public Health ProblemClinical Microbiology Reviews, 2007
- Unexpected Link between Iron and Drug Resistance of Candida spp.: Iron Depletion Enhances Membrane Fluidity and Drug Diffusion, Leading to Drug-SusceptibleCellsAntimicrobial Agents and Chemotherapy, 2006
- Saccharomyces cerevisiae Npc2p Is a Functionally Conserved Homologue of the Human Niemann-Pick Disease Type C 2 Protein, hNPC2Eukaryotic Cell, 2005
- Methylxanthine Drugs Are Chitinase Inhibitors: Investigation of Inhibition and Binding ModesCell Chemical Biology, 2005
- Drug repositioning: identifying and developing new uses for existing drugsNature Reviews Drug Discovery, 2004
- Azide inhibition of mitochondrial electron transport II. Spectral changes induced by azideBiochimica et Biophysica Acta (BBA) - Bioenergetics, 1967